Panel: Turning Strategy into Execution in Pharma Partnerships

Session details:

• Identify the early warning signs that a deal is drifting off track post-signing and how to course-correct quickly 
• Capture and transfer critical deal context (intent, assumptions, success metrics) before BD steps back  
• Establish clear roles, decision rights, and communication channels between BD and execution teams from day one  
• Implement structured handoff frameworks (playbooks, joint transition sessions, governance models) to maintain momentum  
• Define ownership and accountability upfront, with measurable KPIs to ensure the deal delivers long-term value